Major Head and Neck Procedures without CC/MCC DRG Reimbursement

DRG 142 represents major head and neck procedures without Complication or Comorbidity or Major Complication or Comorbidity, covering extensive resections and reconstructions. Proper classification under this Diagnosis-Related Group affects inpatient reimbursement by aligning payment with expected resource use for Medicare hospital stays.

DRG 142 Overview

DRG 142 covers major head and neck surgical procedures without a Complication or Comorbidity or Major Complication or Comorbidity present, typically including extensive resections and complex reconstructive techniques for tumors or severe disease. This category groups inpatient stays with similar resource use and clinical complexity for Medicare payment purposes. Accurate clinical coding and documentation determine assignment to this Diagnosis-Related Group and therefore impact Medicare inpatient reimbursement. The classification separates higher-acuity cases with Complication or Comorbidity or Major Complication or Comorbidity into different payment tiers.

Acute perioperative airway management and complication reduction trials: randomized or observational studies that evaluate protocols, devices, or techniques to prevent airway compromise, hemorrhage, and aspiration during and immediately after major head and neck procedures (e.g., extensive resections, flap reconstructions, laryngectomy-related operations). These studies enroll adult surgical inpatients with complex head and neck pathology who require advanced airway plans or tracheostomy and aim to measure rates of reintubation, emergency airway interventions, perioperative bleeding, and ICU utilization. Findings inform clinicians about best practices to reduce short-term morbidity and inform payers about expected resource use and potential cost drivers in the index hospitalization.
Comparative effectiveness studies of reconstructive approaches and perioperative pathways: multicenter cohort or randomized studies comparing techniques such as free flap versus regional flap reconstruction, or enhanced recovery after surgery (ERAS) protocols versus standard care, for patients undergoing major oncologic head and neck resections. These trials focus on functional outcomes (swallowing, speech), length of stay, complication rates (flap failure, wound infection), and need for revision procedures in patients with cancer-related resections, and provide evidence to guide surgical decision making and bundled payment or utilization management strategies.
Post-discharge recovery, rehabilitation, and readmission prevention studies: prospective observational or intervention trials targeting the post-acute phase, testing structured outpatient rehabilitation programs, telehealth follow-up, nutrition/feeding tube weaning protocols, or care coordination interventions to reduce readmissions and improve long-term functional recovery. Enrolled patients are those discharged after major head and neck surgery who face complex needs (airway care, trach management, dysphagia, wound care), and results are directly relevant to providers and payers seeking to lower 30-day readmissions, optimize post-acute resource allocation, and improve quality metrics tied to this DRG.

Acute perioperative airway management and complication reduction trials: randomized or observational studies that evaluate protocols, devices, or techniques to prevent airway compromise, hemorrhage, and aspiration during and immediately after major head and neck procedures (e.g., extensive resections, flap reconstructions, laryngectomy-related operations). These studies enroll adult surgical inpatients with complex head and neck pathology who require advanced airway plans or tracheostomy and aim to measure rates of reintubation, emergency airway interventions, perioperative bleeding, and ICU utilization. Findings inform clinicians about best practices to reduce short-term morbidity and inform payers about expected resource use and potential cost drivers in the index hospitalization.
Comparative effectiveness studies of reconstructive approaches and perioperative pathways: multicenter cohort or randomized studies comparing techniques such as free flap versus regional flap reconstruction, or enhanced recovery after surgery (ERAS) protocols versus standard care, for patients undergoing major oncologic head and neck resections. These trials focus on functional outcomes (swallowing, speech), length of stay, complication rates (flap failure, wound infection), and need for revision procedures in patients with cancer-related resections, and provide evidence to guide surgical decision making and bundled payment or utilization management strategies.
Post-discharge recovery, rehabilitation, and readmission prevention studies: prospective observational or intervention trials targeting the post-acute phase, testing structured outpatient rehabilitation programs, telehealth follow-up, nutrition/feeding tube weaning protocols, or care coordination interventions to reduce readmissions and improve long-term functional recovery. Enrolled patients are those discharged after major head and neck surgery who face complex needs (airway care, trach management, dysphagia, wound care), and results are directly relevant to providers and payers seeking to lower 30-day readmissions, optimize post-acute resource allocation, and improve quality metrics tied to this DRG.

OpenPayer

Summary & Overview

Major Head and Neck Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 142 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes